TABLE OF CONTENTS
Volume 61, Issue 3 (March 1997)
Pharmacokinetics and Drug Disposition |
Pharmacodynamics and Drug Action |
Clinical Trials and Therapeutics |
USAN Council |
Books Received
Commentaries
Learning versus confirming in clinical drug development
Lewis B. Sheiner MD
Clin Pharmacol Ther 61: 275-291; doi:10.1016/S0009-9236(97)90160-0
Pharmacokinetics and Drug Disposition
Dietary salt increases first-pass elimination of oral quinidine
Dawood Darbar MD, Simonetta Dell'Orto MD, Klaus Mörike MD, Grant R. Wilkinson PhD and Dan M. Roden MD
Clin Pharmacol Ther 61: 292-300; doi:10.1016/S0009-9236(97)90161-2
Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma
Michael A. Amantea PharmD, Alan Forrest PharmD, Donald W. Northfelt MD and Richard Mamelok MD
Clin Pharmacol Ther 61: 301-311; doi:10.1016/S0009-9236(97)90162-4
Bromfenac disposition in patients with impaired kidney function
James C. Ermer MS, Joseph P. Boni PhD, William H. Cevallos PhD, Sheryl DeCleene RN, Peter Burghart MS, Michael R. Rudnick MD, Richard J. Fruncillo MD, PhD, Jeffrey S. Berns MD and Raphael M. Cohen MD
Clin Pharmacol Ther 61: 312-318; doi:10.1016/S0009-9236(97)90163-6
Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4
Hanne Madsen MD, Birgitte Buur Rasmussen MSc and Kim Brøsen MD
Clin Pharmacol Ther 61: 319-324; doi:10.1016/S0009-9236(97)90164-8
Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers
Václav 
pi
ák MD, PhD, Isidore Dab MD, PhD, Réginald Hulhoven MD, PhD, Jean-Pierre Desager PhD, Marie Klánová MD, Marc de Longueville MD and Carl Harvengt MD, PhD
Clin Pharmacol Ther 61: 325-330; doi:10.1016/S0009-9236(97)90165-X
Age and cytochrome P450-linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions
Eero A. Sotaniemi MD, PhD, Arno J. Arranto MD, PhD, Olavi Pelkonen MD, PhD and Markku Pasanen MD, PhD
Clin Pharmacol Ther 61: 331-339; doi:10.1016/S0009-9236(97)90166-1
Pharmacokinetics of nicotine carbomer enemas: A new treatment modality for ulcerative colitis
John T. Green MB, BCh, Gareth A. O. Thomas MD, John Rhodes MD, Brian K. Evans PhD, Michael A. H. Russell BM, BCh, Colin Feyerabend PhD, Grant S. Fuller BSc, Robert G. Newcombe PhD and William J. Sandborn MD
Clin Pharmacol Ther 61: 340-348; doi:10.1016/S0009-9236(97)90167-3
Pharmacodynamics and Drug Action
Effects of tobacco smoking on human ocular smooth pursuit
Edward F. Domino MS, MD, Li Song Ni MS and Huilei Zhang BS
Clin Pharmacol Ther 61: 349-359; doi:10.1016/S0009-9236(97)90168-5
Clinical Trials and Therapeutics
Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1–84)] in healthy postmenopausal volunteers
Hendrik Reinier Schwieter PhD, Edwin W. J. Groen MD, Frans A. E. Sollie PharmD and Jan H. G. Jonkman PhD
Clin Pharmacol Ther 61: 360-376; doi:10.1016/S0009-9236(97)90169-7
The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux
Eric Bellissant MD, PhD, Jean-François Duhamel MD, Marcel Guillot MD, Ann Pariente-Khayat MD, George Olive MD, PharmD and Gerard Pons MD, PhD
Clin Pharmacol Ther 61: 377-384; doi:10.1016/S0009-9236(97)90170-3
Inhibition of cholesterol absorption with CP-148,623 lowers serum cholesterol in humans
William S. Harris PhD, Sheryl L. Windsor MT (ASCP), Fran A. Newton MS and Robert A. Gelfand MD
Clin Pharmacol Ther 61: 385-389; doi:10.1016/S0009-9236(97)90171-5
USAN Council
List No. 391: New Names
Clin Pharmacol Ther 61: 390-393; doi:10.1016/S0009-9236(97)90172-7
